摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-Nitro-6-[(tetrahydro-3-furanyl)oxy]-2-pyridinamine | 1218945-30-2

中文名称
——
中文别名
——
英文名称
3-Nitro-6-[(tetrahydro-3-furanyl)oxy]-2-pyridinamine
英文别名
3-nitro-6-(oxolan-3-yloxy)pyridin-2-amine
3-Nitro-6-[(tetrahydro-3-furanyl)oxy]-2-pyridinamine化学式
CAS
1218945-30-2
化学式
C9H11N3O4
mdl
——
分子量
225.204
InChiKey
QTJGHXVHBHDVDD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    428.3±45.0 °C(Predicted)
  • 密度:
    1.438±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    103
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-Nitro-6-[(tetrahydro-3-furanyl)oxy]-2-pyridinamine 在 palladium 10% on activated carbon 、 氢气 作用下, 以 甲醇二氯甲烷 为溶剂, 生成 6-(Oxolan-3-yloxy)pyridine-2,3-diamine
    参考文献:
    名称:
    Aminoazabenzimidazoles, a Novel Class of Orally Active Antimalarial Agents
    摘要:
    Whole-cell high-throughput screening of the AstraZeneca compound library against the asexual blood stage of Plasmodium falciparum (Pf) led to the identification of amino imidazoles, a robust starting point for initiating a hit-to-lead medicinal chemistry effort. Structure-activity relationship studies followed by pharmacokinetics optimization resulted in the identification of 23 as an attractive lead with good oral bioavailability. Compound 23 was found to be efficacious (ED90 of 28.6 mg.kg(-1)) in the humanized P. falciparum mouse model of malaria (Pf/SCID model). Representative compounds displayed a moderate to fast killing profile that is comparable to that of chloroquine. This series demonstrates no cross-resistance against a panel of Pf strains with mutations to known antimalarial drugs, thereby suggesting a novel mechanism of action for this chemical class.
    DOI:
    10.1021/jm500535j
  • 作为产物:
    参考文献:
    名称:
    Aminoazabenzimidazoles, a Novel Class of Orally Active Antimalarial Agents
    摘要:
    Whole-cell high-throughput screening of the AstraZeneca compound library against the asexual blood stage of Plasmodium falciparum (Pf) led to the identification of amino imidazoles, a robust starting point for initiating a hit-to-lead medicinal chemistry effort. Structure-activity relationship studies followed by pharmacokinetics optimization resulted in the identification of 23 as an attractive lead with good oral bioavailability. Compound 23 was found to be efficacious (ED90 of 28.6 mg.kg(-1)) in the humanized P. falciparum mouse model of malaria (Pf/SCID model). Representative compounds displayed a moderate to fast killing profile that is comparable to that of chloroquine. This series demonstrates no cross-resistance against a panel of Pf strains with mutations to known antimalarial drugs, thereby suggesting a novel mechanism of action for this chemical class.
    DOI:
    10.1021/jm500535j
点击查看最新优质反应信息

文献信息

  • 3H-Imidazo [4, 5-B] Pyridine- 6 -Carboxamides As Anti-Inflammatory Agents
    申请人:Pfau Roland
    公开号:US20120115902A1
    公开(公告)日:2012-05-10
    There are provided compounds of formula (I), wherein R 1 , R 6 , R 8 , Q 2 , Q 3 , Q 3a , Q 4 , L and A have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a member of the MAPEG family is desired and/or required, and particularly in the treatment of inflammation and/or cancer.
    提供了公式(I)的化合物,其中R1、R6、R8、Q2、Q3、Q3a、Q4、L和A的含义在说明中给出,并且其药学上可接受的盐,在希望和/或需要抑制MAPEG家族成员活性的疾病治疗中非常有用,特别是在炎症和/或癌症治疗中。
  • 3H-IMIDAZO[4,5-b]PYRIDINE-6-CARBOXAMIDES AS ANTI-INFLAMMATORY AGENTS
    申请人:Boehringer Ingelheim International GmbH
    公开号:EP2350073A1
    公开(公告)日:2011-08-03
  • US8703796B2
    申请人:——
    公开号:US8703796B2
    公开(公告)日:2014-04-22
  • [EN] 3H-IMIDAZ0 [4, 5-B] PYRIDINE- 6 -CARBOXAMIDES AS ANTI -INFLAMMATORY AGENTS<br/>[FR] 3H-IMIDAZO[4,5-B]PYRIDINE-6-CARBOXAMIDES COMME AGENTS ANTI-INFLAMMATOIRES
    申请人:BOEHRINGER INGELHEIM INT
    公开号:WO2010034799A1
    公开(公告)日:2010-04-01
    There are provided compounds of formula (I), wherein R1, R6, R8, Q2, Q3, Q3a, Q4, L and A have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a member of the MAPEG family is desired and/or required, and particularly in the treatment of inflammation and/or cancer.
  • Aminoazabenzimidazoles, a Novel Class of Orally Active Antimalarial Agents
    作者:Shahul Hameed P、Murugan Chinnapattu、Gajanan Shanbag、Praveena Manjrekar、Krishna Koushik、Anandkumar Raichurkar、Vikas Patil、Sandesh Jatheendranath、Suresh S. Rudrapatna、Shubhada P. Barde、Nikhil Rautela、Disha Awasthy、Sapna Morayya、Chandan Narayan、Stefan Kavanagh、Ramanatha Saralaya、Sowmya Bharath、Pavithra Viswanath、Kakoli Mukherjee、Balachandra Bandodkar、Abhishek Srivastava、Vijender Panduga、Jitender Reddy、K. R. Prabhakar、Achyut Sinha、María Belén Jiménez-Díaz、María Santos Martínez、Iñigo Angulo-Barturen、Santiago Ferrer、Laura María Sanz、Francisco Javier Gamo、Sandra Duffy、Vicky M. Avery、Pamela A. Magistrado、Amanda K. Lukens、Dyann F. Wirth、David Waterson、V. Balasubramanian、Pravin S. Iyer、Shridhar Narayanan、Vinayak Hosagrahara、Vasan K. Sambandamurthy、Sreekanth Ramachandran
    DOI:10.1021/jm500535j
    日期:2014.7.10
    Whole-cell high-throughput screening of the AstraZeneca compound library against the asexual blood stage of Plasmodium falciparum (Pf) led to the identification of amino imidazoles, a robust starting point for initiating a hit-to-lead medicinal chemistry effort. Structure-activity relationship studies followed by pharmacokinetics optimization resulted in the identification of 23 as an attractive lead with good oral bioavailability. Compound 23 was found to be efficacious (ED90 of 28.6 mg.kg(-1)) in the humanized P. falciparum mouse model of malaria (Pf/SCID model). Representative compounds displayed a moderate to fast killing profile that is comparable to that of chloroquine. This series demonstrates no cross-resistance against a panel of Pf strains with mutations to known antimalarial drugs, thereby suggesting a novel mechanism of action for this chemical class.
查看更多